CAR-T cells for pediatric malignancies: Past, present, future and nursing implications

The treatment landscape for pediatric cancers over the last 11 years has undergone a dramatic change, especially with relapsed and refractory B-cell acute lymphoblastic leukemia (ALL), due to the introduction of chimeric antigen receptor-T (CAR-T) cell therapy. Because of the success of CAR-T cell t...

Descripción completa

Detalles Bibliográficos
Autores principales: Callahan, Colleen, Haas, Lauren, Smith, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661550/
https://www.ncbi.nlm.nih.gov/pubmed/38023730
http://dx.doi.org/10.1016/j.apjon.2023.100281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661550/
https://www.ncbi.nlm.nih.gov/pubmed/38023730
http://dx.doi.org/10.1016/j.apjon.2023.100281

Ejemplares similares